Literature DB >> 29468466

Evolving, innovating, and revolutionary changes in cardiovascular imaging: We've only just begun!

Leslee J Shaw1,2, Rory Hachamovitch3, James K Min4, Marcelo Di Carli5, Jennifer H Mieres6, Lawrence Phillips7, Ron Blankstein5, Andrew Einstein8, Viviany R Taqueti5, Robert Hendel9, Daniel S Berman10.   

Abstract

In this review, we highlight the need for innovation and creativity to reinvent the field of nuclear cardiology. Revolutionary ideas brought forth today are needed to create greater value in patient care and highlight the need for more contemporary evidence supporting the use of nuclear cardiology practices. We put forth discussions on the need for disruptive innovation in imaging-guided care that places the imager as a central force in care coordination. Value-based nuclear cardiology is defined as care that is both efficient and effective. Novel testing strategies that defer testing in lower risk patients are examples of the kind of innovation needed in today's healthcare environment. A major focus of current research is the evolution of the importance of ischemia and the prognostic significance of non-obstructive atherosclerotic plaque and coronary microvascular dysfunction. Embracing novel paradigms, such as this, can aid in the development of optimal strategies for coronary disease management. We hope that our article will spurn the field toward greater innovation and focus on transformative imaging leading the way for new generations of novel cardiovascular care.

Entities:  

Keywords:  PET imaging; coronary artery disease; coronary blood flow; diagnostic and prognostic application

Mesh:

Year:  2018        PMID: 29468466     DOI: 10.1007/s12350-018-1225-8

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  37 in total

Review 1.  Network medicine, multimorbidity and the lung in the elderly.

Authors:  Rosa Faner; Tamara Cruz; Alejandra López-Giraldo; Alvar Agustí
Journal:  Eur Respir J       Date:  2014-07-25       Impact factor: 16.671

Review 2.  Coronary artery calcium scanning: past, present, and future.

Authors:  Harvey S Hecht
Journal:  JACC Cardiovasc Imaging       Date:  2015-05

3.  Coronary Artery Calcium and Shared Decision Making.

Authors:  Harvey S Hecht; Leslee J Shaw; Y Chandrashekhar; Jagat Narula
Journal:  JACC Cardiovasc Imaging       Date:  2016-05

4.  Comparison of Coronary CT Angiography, SPECT, PET, and Hybrid Imaging for Diagnosis of Ischemic Heart Disease Determined by Fractional Flow Reserve.

Authors:  Ibrahim Danad; Pieter G Raijmakers; Roel S Driessen; Jonathon Leipsic; Rekha Raju; Chris Naoum; Juhani Knuuti; Maija Mäki; Richard S Underwood; James K Min; Kimberly Elmore; Wynand J Stuijfzand; Niels van Royen; Igor I Tulevski; Aernout G Somsen; Marc C Huisman; Arthur A van Lingen; Martijn W Heymans; Peter M van de Ven; Cornelis van Kuijk; Adriaan A Lammertsma; Albert C van Rossum; Paul Knaapen
Journal:  JAMA Cardiol       Date:  2017-10-01       Impact factor: 14.676

5.  Effect of Care Guided by Cardiovascular Magnetic Resonance, Myocardial Perfusion Scintigraphy, or NICE Guidelines on Subsequent Unnecessary Angiography Rates: The CE-MARC 2 Randomized Clinical Trial.

Authors:  John P Greenwood; David P Ripley; Colin Berry; Gerry P McCann; Sven Plein; Chiara Bucciarelli-Ducci; Erica Dall'Armellina; Abhiram Prasad; Petra Bijsterveld; James R Foley; Kenneth Mangion; Mark Sculpher; Simon Walker; Colin C Everett; David A Cairns; Linda D Sharples; Julia M Brown
Journal:  JAMA       Date:  2016-09-13       Impact factor: 56.272

6.  Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease.

Authors:  Viviany R Taqueti; Brendan M Everett; Venkatesh L Murthy; Mariya Gaber; Courtney R Foster; Jon Hainer; Ron Blankstein; Sharmila Dorbala; Marcelo F Di Carli
Journal:  Circulation       Date:  2014-12-05       Impact factor: 29.690

7.  CAD-RADS(TM) Coronary Artery Disease - Reporting and Data System. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology.

Authors:  Ricardo C Cury; Suhny Abbara; Stephan Achenbach; Arthur Agatston; Daniel S Berman; Matthew J Budoff; Karin E Dill; Jill E Jacobs; Christopher D Maroules; Geoffrey D Rubin; Frank J Rybicki; U Joseph Schoepf; Leslee J Shaw; Arthur E Stillman; Charles S White; Pamela K Woodard; Jonathon A Leipsic
Journal:  J Cardiovasc Comput Tomogr       Date:  2016-06-15

8.  Use of Coronary Computed Tomographic Angiography to Guide Management of Patients With Coronary Disease.

Authors:  Michelle C Williams; Amanda Hunter; Anoop S V Shah; Valentina Assi; Stephanie Lewis; Joel Smith; Colin Berry; Nicholas A Boon; Elizabeth Clark; Marcus Flather; John Forbes; Scott McLean; Giles Roditi; Edwin J R van Beek; Adam D Timmis; David E Newby
Journal:  J Am Coll Cardiol       Date:  2016-04-19       Impact factor: 24.094

9.  Investigation of patients presenting with chest pain.

Authors:  Adam Timmis
Journal:  Heart       Date:  2015-02-16       Impact factor: 5.994

10.  Coronary plaque quantification and fractional flow reserve by coronary computed tomography angiography identify ischaemia-causing lesions.

Authors:  Sara Gaur; Kristian Altern Øvrehus; Damini Dey; Jonathon Leipsic; Hans Erik Bøtker; Jesper Møller Jensen; Jagat Narula; Amir Ahmadi; Stephan Achenbach; Brian S Ko; Evald Høj Christiansen; Anne Kjer Kaltoft; Daniel S Berman; Hiram Bezerra; Jens Flensted Lassen; Bjarne Linde Nørgaard
Journal:  Eur Heart J       Date:  2016-01-12       Impact factor: 29.983

View more
  1 in total

1.  Cardiac Graft Assessment in the Era of Machine Perfusion: Current and Future Biomarkers.

Authors:  Martina Bona; Rahel K Wyss; Maria Arnold; Natalia Méndez-Carmona; Maria N Sanz; Dominik Günsch; Lucio Barile; Thierry P Carrel; Sarah L Longnus
Journal:  J Am Heart Assoc       Date:  2021-01-30       Impact factor: 5.501

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.